3- (4- methoxy)phenyl- 4- ((4- (2- (1- piperidinyl)ethoxy)phenyl)methyl)- 2H- 1- benzopyran- 7- ol

an estrogen receptor modulator; CHF-4227 is the HCL salt; structure in first source

Also Known As:

CHF 4227; CHF-4227; CHF4227

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Amari, Gabriele: 1 article (10/2002)
2.	Armani, Elisabetta: 1 article (10/2002)
3.	Caruso, Paola Lorenza: 1 article (10/2002)
4.	Civelli, Maurizio: 1 article (10/2002)
5.	Delcanale, Maurizio: 1 article (10/2002)
6.	Galbiati, Elisabetta: 1 article (10/2002)
7.	Ghirardi, Silvia: 1 article (10/2002)

1.	Neoplasms (Cancer) 10/01/2002 - "In line with its estrogen antagonist effect, CHF 4227 significantly prevented the development of dimethylbenz[a]anthracene (DMBA)-induced mammary tumors, the incidence being reduced from 87.5 to 26.3% 6 months after DMBA administration. "